RecruitingNCT00872495

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer of the Bladder and Kidney


Sponsor

Lahey Clinic

Enrollment

500 participants

Start Date

Sep 1, 2002

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating urine-based tests for detecting bladder cancer, comparing them against standard procedures like cystoscopy (a camera examination of the bladder). **You may be eligible if...** - You are over 18 years old - You are scheduled for a cystoscopy (bladder scope procedure) — either for newly diagnosed bladder cancer or routine follow-up for known bladder cancer - OR you are in the control group: no known bladder cancer and willing to provide one urine sample **You may NOT be eligible if...** - You are under 18 years old Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Lahey Clinic, Inc.

Burlington, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00872495


Related Trials